CLARIS’S PORTFOLIO COMPANIES RECEIVE EASY ACCESS TO EVOTEC’S FULL RANGE OF PRE-CLINICAL AND CLINICAL DEVELOPMENT AND MANUFACTURING CAPABILITIES Hamburg, Germany, and Turin, […]
Claris Ventures appoints pharmaceutical industry veteran Michael Hodges as a Partner Claris Ventures appoints pharmaceutical industry veteran Michael Hodges as a Partner […]
Sibylla Biotech Raises €23 Million Series A to Advance Protein Degradation by Folding Interference Pipeline and Expand Technology Platform Sibylla Biotech Raises […]
Iama Therapeutics Raises €8 Million Series A IAMA THERAPEUTICS RACCOGLIE 8 MILIONI DI EURO PER LO SVILUPPO DI UN NUOVO CANDIDATO FARMACO […]
Heqet Therapeutics raises €8m to advance its RNA-based therapeutic program for cardiac regeneration March 23rd, 2022 – Heqet Therapeutics, a King’s College London […]
Kither Biotech Raises €18.5 Million Series B Kither Biotech Raises €18.5 Million Series B and Appoints Dr. Vincent Metzler as Chief Executive […]
Claris Ventures announces final closing: €85m ($100m) for Italian Biotech Fund oversubscription, one year after its launch by the Turin based SGR […]
NeoPhore Announces $21m Financing to Advance DNA Mismatch Repair Pipeline Round led by Claris Ventures with 2Invest, 3B Future Health Fund and […]
Primo closing a quota €30m per Claris Biotech I, fondo biotech promosso da Claris Ventures SGR Torino, 1 settembre 2020 – Claris […]
La rivista Prisma dedica un articolo a Claris Ventures La rivista Prisma nel mese di aprile dedica un articolo a Claris Ventures. […]
